BIB

Ultra Nasdaq Biotechnology

BIB seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

How to Buy
Why BIB?
Target Magnified Returns

BIB is the only ETF that targets 2x the daily returns of the Biotechnology industry.

Efficient

BIB offers 2x exposure with less cash.

Convenience

Buy and sell leveraged exposure via a single ticker in a brokerage account.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”).

While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target.

The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB NAV -7.55% 2.21% 37.13% 2.21% 70.94% 15.59% 0.06% 7.43% 16.31% 04/07/2010
BIB Market Price -7.52% 2.18% 37.06% 2.18% 70.63% 15.62% 0.04% 7.44% 16.31% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $82,744,882
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/22/2026
  • NAV
    $87.10
  • NAV Change
    $+0.15 up caret
  • Market Price
    $87.03
  • Market Price Change
    $+0.14 up caret
  • Trading Volume (M)
    15,247
  • 30-Day Median Bid Ask Spread
    0.25%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $82,744,882
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/22/2026
  • NAV
    $87.10
  • NAV Change
    $+0.15 up caret
  • Market Price
    $87.03
  • Market Price Change
    $+0.14 up caret
  • Trading Volume (M)
    15,247
  • 30-Day Median Bid Ask Spread
    0.25%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2026. Without the fee waiver performance would likely be lower.

Exposures

Index as of 3/31/2026

Holdings

as of 4/22/2026

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
4.64% GILD GILEAD SCIENCES INC -- $3,799,743.90 28,591 2369174
4.64% AMGN AMGEN INC -- $3,795,088.32 10,971 2023607
4.58% VRTX VERTEX PHARMACEUTICALS INC -- $3,750,831.90 8,570 2931034
3.92% REGN REGENERON PHARMACEUTICALS -- $3,208,800.84 4,298 2730190
2.08% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,703,841.88 5,486 B00FWN1
1.57% INSM INSMED INC -- $1,288,761.60 8,920 2614487
1.42% RVMD REVOLUTION MEDICINES INC -- $1,160,300.00 8,200 BL71K91
1.41% BIIB BIOGEN INC -- $1,153,914.97 6,071 2455965
1.27% UTHR UNITED THERAPEUTICS CORP -- $1,041,187.77 1,813 2430412
1.14% ARGX ARGENX SE - ADR -- $931,240.28 1,174 BDVLM39
1.11% MRNA MODERNA INC -- $908,615.20 16,342 BGSXTS3
1.08% RPRX ROYALTY PHARMA PLC- CL A -- $881,436.16 17,728 BMVP7Y0
1.05% ROIV ROIVANT SCIENCES LTD -- $863,452.15 29,621 BMW4NZ9
1.01% ILMN ILLUMINA INC -- $825,804.00 6,328 2613990
0.97% INCY INCYTE CORP -- $796,847.38 8,237 2471950
0.96% SMMT SUMMIT THERAPEUTICS INC -- $788,723.04 32,088 BMTVQS7
0.85% VTRS VIATRIS INC -- $691,863.48 47,649 BMWS3X9
0.73% BBIO BRIDGEBIO PHARMA INC -- $597,232.12 8,023 BK1KWG8
0.73% MEDP MEDPACE HOLDINGS INC -- $596,932.04 1,174 BDCBC61
0.72% -- ASCENDIS PHARMA A/S -- $588,484.35 2,547 --
0.67% NBIX NEUROCRINE BIOSCIENCES INC -- $544,921.72 4,154 2623911
0.63% JAZZ JAZZ PHARMACEUTICALS PLC -- $515,512.80 2,547 B4Q5ZN4
0.63% BNTX BIONTECH SE-ADR -- $512,049.00 4,715 BK6H543
0.62% IONS IONIS PHARMACEUTICALS INC -- $511,612.71 6,837 BDJ0LS6
0.62% EXEL EXELIXIS INC -- $503,543.80 10,748 2576941
0.61% MDGL MADRIGAL PHARMACEUTICALS INC -- $502,683.00 950 BD59BS7
0.59% GH GUARDANT HEALTH INC -- $485,952.56 5,426 BFXC911
0.58% SNY SANOFI-ADR -- $474,956.30 10,127 2964557
0.53% BMRN BIOMARIN PHARMACEUTICAL INC -- $430,979.85 7,959 2437071
0.52% ARWR ARROWHEAD PHARMACEUTICALS IN -- $428,514.24 5,797 BYQBFJ8
0.50% ONC BEONE MEDICINES LTD-ADR -- $413,318.43 1,323 BYYWPW6
0.49% TEM TEMPUS AI INC-CL A -- $399,005.88 7,188 BSLSJJ0
0.48% AXSM AXSOME THERAPEUTICS INC -- $394,651.14 2,117 BYZR4X4
0.48% PRAX PRAXIS PRECISION MEDICINES I -- $388,895.37 1,153 BQ721R4
0.44% PCVX VAXCYTE INC -- $362,123.55 5,955 BKPVGH6
0.42% IBRX IMMUNITYBIO INC -- $343,370.43 42,549 BNSP0B8
0.41% CYTK CYTOKINETICS INC -- $337,742.50 5,098 BBBSBJ5
0.41% KRYS KRYSTAL BIOTECH INC -- $334,439.28 1,212 BD6JX35
0.41% HALO HALOZYME THERAPEUTICS INC -- $334,065.60 4,884 2975098
0.40% NUVL NUVALENT INC-A -- $329,815.50 3,030 BMVBZD3
0.37% KYMR KYMERA THERAPEUTICS INC -- $299,776.29 3,377 BMPRZV5
0.36% ABVX ABIVAX SA-ADR -- $294,730.59 2,541 BLC89B2
0.34% PTGX PROTAGONIST THERAPEUTICS INC -- $278,757.55 2,641 BDCBCD8
0.34% ERAS ERASCA INC -- $277,423.10 12,814 BNLYBF3
0.30% IMVT IMMUNOVANT INC -- $248,482.74 8,426 BJRFSB7
0.30% COGT COGENT BIOSCIENCES INC -- $244,468.02 6,718 BLR6XK8
0.30% CGON CG ONCOLOGY INC -- $244,160.72 3,494 BRBCSP4
0.30% PTCT PTC THERAPEUTICS INC -- $242,590.40 3,424 B17VCN9
0.29% RYTM RHYTHM PHARMACEUTICALS INC -- $240,704.55 2,826 BF2YWG4
0.29% CAI CARIS LIFE SCIENCES INC -- $239,399.00 11,678 BT18HP9
0.29% SYRE SPYRE THERAPEUTICS INC -- $237,177.00 3,249 BQBBDY8
0.29% MIRM MIRUM PHARMACEUTICALS INC -- $235,492.07 2,497 BJDX8Y8
0.28% ALKS ALKERMES PLC -- $232,704.78 6,897 B3P6D26
0.28% TERN TERNS PHARMACEUTICALS INC -- $232,548.84 4,401 BMDJ0C9
0.27% CRSP CRISPR THERAPEUTICS AG -- $224,100.24 3,972 BDHF4K6
0.26% APLS APELLIS PHARMACEUTICALS INC -- $216,308.10 5,290 BYTQ6X1
0.25% APGE APOGEE THERAPEUTICS INC -- $205,662.24 2,268 BM9HHL5
0.24% SRRK SCHOLAR ROCK HOLDING CORP -- $199,874.59 4,223 BFZQ0L8
0.24% CNTA CENTESSA PHARMACEUTICALS-ADR -- $195,376.50 4,950 BLB0YQ9
0.24% XENE XENON PHARMACEUTICALS INC -- $195,045.95 3,443 BRJ3GY4
0.23% LGND LIGAND PHARMACEUTICALS -- $186,940.88 824 2501578
0.21% INDV INDIVIOR PHARMACEUTICALS INC -- $172,726.47 5,173 BTZRLN8
0.21% CRNX CRINETICS PHARMACEUTICALS IN -- $169,420.30 4,333 BDD19F8
0.20% AMRX AMNEAL PHARMACEUTICALS INC -- $166,916.40 13,020 BFNF1D6
0.20% TWST TWIST BIOSCIENCE CORP -- $160,401.60 2,538 BGKG6G7
0.19% ACAD ACADIA PHARMACEUTICALS INC -- $156,858.72 7,053 2713317
0.19% TVTX TRAVERE THERAPEUTICS INC -- $153,063.62 3,818 BLFGJD5
0.19% -- NEWAMSTERDAM PHARMA CO NV -- $151,906.64 4,756 BP8JSP4
0.18% TNGX TANGO THERAPEUTICS INC -- $150,163.56 5,574 BP2P6L0
0.18% GPCR STRUCTURE THERAPEUTICS INC -- $150,009.00 3,226 BQS9486
0.17% EWTX EDGEWISE THERAPEUTICS INC -- $142,802.63 4,439 BKY5JZ8
0.17% ORKA ORUKA THERAPEUTICS INC -- $139,569.04 2,003 BKVF0J2
0.17% ALMS ALUMIS INC -- $135,456.48 5,232 BPLQG36
0.16% DYN DYNE THERAPEUTICS INC -- $133,992.04 6,812 BN15WD1
0.16% BEAM BEAM THERAPEUTICS INC -- $133,605.04 4,216 BK6L288
0.16% DNLI DENALI THERAPEUTICS INC -- $132,880.50 6,562 BD2B4V0
0.15% RLAY RELAY THERAPEUTICS INC -- $122,124.47 7,397 BN2R582
0.15% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $121,790.00 5,128 BKX9VD3
0.15% SUPN SUPERNUS PHARMACEUTICALS INC -- $119,338.17 2,373 B72ZBG4
0.15% VERA VERA THERAPEUTICS INC -- $118,917.31 2,953 BL55460
0.14% IDYA IDEAYA BIOSCIENCES INC -- $115,120.45 3,635 BK0VHF6
0.14% KOD KODIAK SCIENCES INC -- $114,149.94 2,526 BFXC933
0.14% TARS TARSUS PHARMACEUTICALS INC -- $111,788.28 1,761 BMH5RL1
0.14% TXG 10X GENOMICS INC-CLASS A -- $111,136.44 4,868 BKS3RS7
0.14% VCYT VERACYTE INC -- $110,939.61 3,291 BFTWZY0
0.13% IRON DISC MEDICINE INC -- $110,141.80 1,580 BMGJZJ8
0.13% ELVN ENLIVEN THERAPEUTICS INC -- $109,189.08 2,457 BMFD115
0.13% ADMA ADMA BIOLOGICS INC -- $107,934.15 9,857 B9NSBM2
0.12% RARE ULTRAGENYX PHARMACEUTICAL IN -- $98,415.39 3,999 BJ62Z18
0.12% DFTX DEFINIUM THERAPEUTICS INC -- $95,228.08 4,126 BV2DHY6
0.12% MLYS MINERALYS THERAPEUTICS INC -- $94,774.68 3,276 BP9N0G0
0.11% BCRX BIOCRYST PHARMACEUTICALS INC -- $93,532.81 10,381 2100362
0.11% LEGN LEGEND BIOTECH CORP-ADR -- $90,547.56 3,492 BMX9K07
0.11% ADPT ADAPTIVE BIOTECHNOLOGIES -- $90,482.40 6,372 BJ5FZ74
0.11% AUPH AURINIA PHARMACEUTICALS INC -- $90,342.84 5,502 BFWLC09
0.11% SRPT SAREPTA THERAPEUTICS INC -- $89,515.68 4,337 B8DPDT7
0.11% ZYME ZYMEWORKS INC -- $88,414.47 3,099 BPCQZY9
0.11% OCUL OCULAR THERAPEUTIX INC -- $87,026.94 9,009 BNZB1X8
0.10% STOK STOKE THERAPEUTICS INC -- $84,831.70 2,363 BJQ05Z6
0.10% GRAL GRAIL INC -- $84,738.60 1,611 BSLSSX7
0.10% TYRA TYRA BIOSCIENCES INC -- $82,468.80 2,208 BMVNDH9
0.10% KNSA KINIKSA PHARMACEUTICALS INTE -- $81,819.04 1,901 BRXB0C0
0.10% NTLA INTELLIA THERAPEUTICS INC -- $80,994.16 4,888 BYZM6C2
0.10% SNDX SYNDAX PHARMACEUTICALS INC -- $80,614.08 3,651 BN7Q7R7
0.10% RXRX RECURSION PHARMACEUTICALS-A -- $80,571.73 21,601 BM9FJ13
0.10% SION SIONNA THERAPEUTICS INC -- $79,833.60 1,848 BQKXDX4
0.10% PHVS PHARVARIS NV -- $79,666.08 2,652 BMZ2X38
0.10% AMLX AMYLYX PHARMACEUTICALS INC -- $79,663.44 4,547 BPCK358
0.10% TRVI TREVI THERAPEUTICS INC -- $78,514.00 5,305 BJH9ZN0
0.09% HRMY HARMONY BIOSCIENCES HOLDINGS -- $76,536.18 2,394 BKSGZN7
0.09% TSHA TAYSHA GENE THERAPIES INC -- $76,164.48 11,334 BNC1BX1
0.09% ANIP ANI PHARMACEUTICALS INC -- $74,369.92 928 BCDWBX6
0.09% GMAB GENMAB A/S -SP ADR -- $73,793.85 2,665 BBC9WC7
0.09% RAPP RAPPORT THERAPEUTICS INC -- $72,566.94 1,973 BR3T9B6
0.09% VCEL VERICEL CORP -- $72,245.74 2,102 BSBMN89
0.09% INVA INNOVIVA INC -- $72,004.00 3,064 BDDXF67
0.09% ATAI ATAIBECKLEY INC -- $70,791.30 15,030 BWJDYK1
0.09% NRIX NURIX THERAPEUTICS INC -- $70,777.28 4,256 BMVLGP2
0.08% VIR VIR BIOTECHNOLOGY INC -- $69,387.01 6,503 BK4PZ38
0.08% INBX INHIBRX BIOSCIENCES INC -- $69,169.09 601 BNSP8K3
0.08% GLUE MONTE ROSA THERAPEUTICS INC -- $66,233.86 3,157 BP7KZP7
0.08% AGIO AGIOS PHARMACEUTICALS INC -- $64,769.28 2,424 BCBVTX1
0.08% MBX MBX BIOSCIENCES INC -- $62,358.06 1,857 BQXJKH2
0.08% BCAX BICARA THERAPEUTICS INC -- $61,957.86 2,622 BQB42F1
0.08% ANAB ANAPTYSBIO INC -- $61,475.40 1,148 BDRW1L7
0.07% NVCR NOVOCURE LTD -- $61,311.18 4,709 BYSS4X4
0.07% ARDX ARDELYX INC -- $61,090.96 10,148 BN89V40
0.07% CRVS CORVUS PHARMACEUTICALS INC -- $61,011.30 3,418 BYP80F1
0.07% IOVA IOVANCE BIOTHERAPEUTICS INC -- $60,179.44 17,048 BF0DMK7
0.07% HROW HARROW INC -- $60,119.04 1,536 BHNDW86
0.07% PGEN PRECIGEN INC -- $57,994.20 14,645 BKM5C84
0.07% WVE WAVE LIFE SCIENCES LTD -- $57,497.58 7,791 BYZG9R0
0.07% NVAX NOVAVAX INC -- $56,953.00 6,740 BJDQXG4
0.07% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $54,383.72 1,814 BLCD809
0.07% OLMA OLEMA PHARMACEUTICALS INC -- $53,851.84 3,316 BMZ4LN0
0.06% AVBP ARRIVENT BIOPHARMA INC -- $52,830.45 1,710 BMGTLY5
0.06% MAZE MAZE THERAPEUTICS INC -- $52,761.50 1,991 BSRK699
0.06% ABCL ABCELLERA BIOLOGICS INC -- $51,187.68 12,546 BL53SR3
0.06% URGN UROGEN PHARMA LTD -- $50,452.16 1,936 BZ7PJQ1
0.06% EYPT EYEPOINT INC -- $48,772.00 3,425 BMGS7L1
0.06% GHRS GH RESEARCH PLC -- $48,663.60 2,568 BP6C0S2
0.06% SEPN SEPTERNA INC -- $47,866.86 1,851 BQNKXX2
0.06% ALVO ALVOTECH SA -- $47,845.00 13,670 BPNTJ34
0.06% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $46,036.41 853 BL95N25
0.06% QURE UNIQURE NV -- $45,836.84 2,578 BJFSR88
0.06% ZBIO ZENAS BIOPHARMA INC -- $45,277.92 2,256 BQB42H3
0.05% ORIC ORIC PHARMACEUTICALS INC -- $44,738.58 4,154 BKVDFF7
0.05% COLL COLLEGIUM PHARMACEUTICAL INC -- $43,440.84 1,314 BX7RSN3
0.05% SVRA SAVARA INC -- $43,294.22 8,423 BYXGN81
0.05% GRFS GRIFOLS SA-ADR -- $42,335.94 5,046 B8K7T65
0.05% PCRX PACIRA BIOSCIENCES INC -- $41,624.24 1,673 B3X26D8
0.05% XERS XERIS BIOPHARMA HOLDINGS INC -- $41,476.68 6,867 BLR7H87
0.05% GERN GERON CORP -- $40,949.45 26,419 2370381
0.05% KALV KALVISTA PHARMACEUTICALS INC -- $40,919.52 2,092 BD06CS0
0.05% SANA SANA BIOTECHNOLOGY INC -- $40,678.56 11,024 BMFJJ97
0.05% FTRE FORTREA HOLDINGS INC -- $40,624.50 3,869 BRXYZ57
0.05% AMPH AMPHASTAR PHARMACEUTICALS IN -- $39,398.23 1,877 BNFWZS4
0.05% OMER OMEROS CORP -- $39,200.84 2,932 B4NB858
0.05% XNCR XENCOR INC -- $39,025.45 3,037 BGCYWN8
0.05% JANX JANUX THERAPEUTICS INC -- $38,752.02 2,518 BMFX8Y7
0.05% PHAT PHATHOM PHARMACEUTICALS INC -- $38,239.80 3,260 BJLKVS6
0.05% ANNX ANNEXON INC -- $37,491.14 5,989 BMVV9R5
0.04% ABUS ARBUTUS BIOPHARMA CORP -- $35,258.37 7,959 BZ0QMB7
0.04% MNKD MANNKIND CORP -- $34,940.48 12,752 BF081J4
0.04% TBPH THERAVANCE BIOPHARMA INC -- $34,763.86 2,098 BMNDK09
0.04% SPRY ARS PHARMACEUTICALS INC -- $34,372.80 4,092 BMCR7V2
0.04% KURA KURA ONCOLOGY INC -- $34,317.53 3,601 BYZD465
0.04% CMPS COMPASS PATHWAYS PLC -- $34,160.00 3,904 BMC3HS7
0.04% MESO MESOBLAST LTD- SPON ADR -- $34,077.10 2,165 BQS7491
0.04% CGEM CULLINAN THERAPEUTICS INC -- $33,852.64 2,446 BM90J52
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $33,409.93 3,331 BFYQFJ2
0.04% BIOA BIOAGE LABS INC -- $32,992.92 1,797 BT9K6D8
0.04% ZLAB ZAI LAB LTD-ADR -- $32,429.66 1,418 BD9GVY0
0.04% CTMX CYTOMX THERAPEUTICS INC -- $32,320.71 7,011 BYWVTY5
0.04% DSGN DESIGN THERAPEUTICS INC -- $31,499.72 2,356 BMFK3H6
0.04% CSTL CASTLE BIOSCIENCES INC -- $30,873.00 1,230 BKLCWZ3
0.04% PRME PRIME MEDICINE INC -- $29,581.20 7,470 BPBJFM7
0.03% ARVN ARVINAS INC -- $28,148.24 2,648 BDZ30Q0
0.03% IRWD IRONWOOD PHARMACEUTICALS INC -- $28,148.12 6,734 B3MZ6K5
0.03% PSNL PERSONALIS INC -- $27,322.30 4,330 BJQ0608
0.03% SLDB SOLID BIOSCIENCES INC -- $27,106.80 3,227 BQHN6C7
0.03% VOR VOR BIOPHARMA INC -- $26,365.72 1,721 BRJJYT3
0.03% ETON ETON PHARMACEUTICALS INC -- $26,183.49 1,109 BGL0JK3
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $24,420.72 2,328 BLFBZ32
0.03% CRMD CORMEDIX INC -- $24,417.40 3,260 BJ0LT31
0.03% KYTX KYVERNA THERAPEUTICS INC -- $24,183.72 2,364 BSMLR16
0.03% PRTA PROTHENA CORP PLC -- $23,862.72 2,226 B91XRN2
0.03% RIGL RIGEL PHARMACEUTICALS INC -- $22,943.91 753 BQD3J33
0.03% ABSI ABSCI CORP -- $22,900.64 6,223 BN94K69
0.03% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $22,354.02 6,058 BMCWKZ2
0.03% ALLO ALLOGENE THERAPEUTICS INC -- $22,229.39 9,301 BFZNYB7
0.03% CADL CANDEL THERAPEUTICS INC -- $22,210.84 3,026 BP0TQC5
0.03% TECX TECTONIC THERAPEUTIC INC -- $22,173.00 778 BPBPCG8
0.03% ACRS ACLARIS THERAPEUTICS INC -- $21,901.71 4,989 BYV2W40
0.03% LYEL LYELL IMMUNOPHARMA INC -- $21,781.62 879 BTNMG41
0.03% TRAX FIRST TRACKS BIOTHERAPEUTICS -- $21,662.76 1,148 BS2CR64
0.03% UPB UPSTREAM BIO INC -- $21,555.04 2,236 BRCFFK6
0.03% PACB PACIFIC BIOSCIENCES OF CALIF -- $21,371.58 12,498 B4N8MH9
0.03% FULC FULCRUM THERAPEUTICS INC -- $21,351.25 2,755 BJDX8Z9
0.03% AQST AQUESTIVE THERAPEUTICS INC -- $20,945.05 5,047 BYVQJ96
0.03% TRDA ENTRADA THERAPEUTICS INC -- $20,697.30 1,586 BP81RK8
0.03% FDMT 4D MOLECULAR THERAPEUTICS IN -- $20,678.00 2,110 BKLXFX5
0.03% LRMR LARIMAR THERAPEUTICS INC -- $20,488.08 4,493 BMXNGZ6
0.02% KMDA KAMADA LTD -- $19,955.32 2,387 B2Q9833
0.02% AURA AURA BIOSCIENCES INC -- $19,676.23 2,627 BP81R42
0.02% RGNX REGENXBIO INC -- $19,567.30 2,095 BZ0G875
0.02% ESPR ESPERION THERAPEUTICS INC -- $19,487.24 9,892 BBNBTD2
0.02% LXEO LEXEO THERAPEUTICS INC -- $19,122.93 3,021 BQ6C357
0.02% IVVD INVIVYD INC -- $18,347.20 11,467 BM8NHS1
0.02% AVIR ATEA PHARMACEUTICALS INC -- $18,125.91 3,231 BLN9Z50
0.02% ALT ALTIMMUNE INC -- $17,978.07 5,181 BFY7DC4
0.02% GLPG GALAPAGOS NV-SPON ADR -- $17,891.96 614 B292NQ7
0.02% NGNE NEUROGENE INC -- $17,452.80 640 BS2F741
0.02% RCKT ROCKET PHARMACEUTICALS INC -- $17,077.20 4,494 BDFKQ07
0.02% VNDA VANDA PHARMACEUTICALS INC -- $16,781.31 2,457 B12W3P6
0.02% ENTA ENANTA PHARMACEUTICALS INC -- $16,575.58 1,202 B9L5200
0.02% CTNM CONTINEUM THERAPEUTICS INC-A -- $16,329.60 1,260 BPRBTY7
0.02% NMRA NEUMORA THERAPEUTICS INC -- $15,978.27 6,917 BN4JN37
0.02% PBYI PUMA BIOTECHNOLOGY INC -- $15,632.72 2,104 B7F2TY6
0.02% IMRX IMMUNEERING CORP - CLASS A -- $15,626.17 2,653 BMVBZF5
0.02% SLN SILENCE THERAPEUTICS PLC-ADR -- $15,485.71 1,943 BL5B6Z1
0.02% KROS KEROS THERAPEUTICS INC -- $14,425.84 1,261 BM7V485
0.02% EOLS EVOLUS INC -- $13,919.58 2,682 BDRJH21
0.02% AVXL ANAVEX LIFE SCIENCES CORP -- $13,851.57 3,837 BYTYP72
0.02% EDIT EDITAS MEDICINE INC -- $13,453.20 4,040 BZ8FPH3
0.02% SIGA SIGA TECHNOLOGIES INC -- $13,372.15 2,965 2107437
0.02% AUTL AUTOLUS THERAPEUTICS PLC -- $13,284.80 8,303 BFMLGR4
0.02% FHTX FOGHORN THERAPEUTICS INC -- $13,059.97 2,423 BMF7DT9
0.02% LENZ LENZ THERAPEUTICS INC -- $12,927.06 1,294 BQV0J03
0.02% ACIU AC IMMUNE SA -- $12,744.90 4,165 BZC0D70
0.02% CABA CABALETTA BIO INC -- $12,622.94 3,982 BK5MWR1
0.02% CCCC C4 THERAPEUTICS INC -- $12,396.66 4,038 BKX9NQ0
0.01% NBP NOVABRIDGE BIOSCIENCES -- $11,984.10 4,645 BKRRKY7
0.01% CHRS COHERUS ONCOLOGY INC -- $11,134.80 6,186 BRK0149
0.01% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $10,137.12 1,176 BKC9SX3
0.01% VYGR VOYAGER THERAPEUTICS INC -- $10,101.60 2,440 BY7RB53
0.01% OBIO ORCHESTRA BIOMED HOLDINGS IN -- $9,834.56 2,336 BPRB2N7
0.01% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $9,560.84 1,916 BKDQKM6
0.01% CDXS CODEXIS INC -- $9,230.39 3,737 B5LL2C2
0.01% CRBU CARIBOU BIOSCIENCES INC -- $9,126.12 3,867 BNYJR68
0.01% OABI OMNIAB INC -- $8,934.00 5,956 BN13S71
0.01% QSI QUANTUM-SI INC -- $8,572.22 8,087 BNR5QT9
0.01% LFCR LIFECORE BIOMEDICAL INC -- $8,096.04 1,548 2517058
0.01% SGMT SAGIMET BIOSCIENCES INC-A -- $8,063.52 1,284 BP2NYN2
0.01% BDTX BLACK DIAMOND THERAPEUTICS I -- $7,895.95 2,357 BKTV702
0.01% REPL REPLIMUNE GROUP INC -- $7,758.86 3,418 BDDVW37
0.01% TKNO ALPHA TEKNOVA INC -- $7,132.30 2,215 BP7L561
0.01% MENS JYONG BIOTECH LTD -- $7,001.88 3,071 BPTK6Z2
0.01% TNYA TENAYA THERAPEUTICS INC -- $6,603.55 8,971 BNNXX52
0.01% HUMA HUMACYTE INC -- $5,630.74 7,988 BMYTJP4
0.01% AARD AARDVARK THERAPEUTICS INC -- $4,982.53 901 BTXQTX3
0.01% PYXS PYXIS ONCOLOGY INC -- $4,844.76 2,577 BLBR8D5
0.01% PEPG PEPGEN INC -- $4,726.02 2,847 BMTX3D7
-- RANI RANI THERAPEUTICS HOLDINGS-A -- $3,835.15 4,037 BNNXX18
-- GOSS GOSSAMER BIO INC -- $3,734.07 9,577 BJ0CK86
-- THRD THIRD HARMONIC BIO INC -- $00.00 1,662 BNNPQY8
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
38.00% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 31,107,537 -- 5,140 --
29.32% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 24,002,430 -- 3,966 --
27.37% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 22,404,689 -- 3,702 --
19.51% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 15,971,360 -- 2,639 --
16.27% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 13,320,562 -- 2,201 --
4.68% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 3,830,948 -- 633 --
-- -- NET OTHER ASSETS (LIABILITIES) -- $28,908,001.17 28,908,001 --

Index

as of 3/31/2026

  • Total Number of Companies256
  • Price/Book Ratio3.78
  • Dividend Yield ( % )0.85
  • Avg. Index Market Capitalization$6.50 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.